Progenesis的封面图片
Progenesis

Progenesis

生物技术研究

La Jolla,California 6,050 位关注者

Setting the Gold Standards in Reproductive Genetics: We Help you Start a Healthy Family.

关于我们

Progenesis is the first company in the US to introduce Next Generation Sequencing (NGS) for Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Preimplantation Genetic Testing for Monogenic disorders (PGT-M). We offer embryo screening for many common diseases including cystic fibrosis, Fragile X syndrome, sickle cell disease, and Tay-Sachs disease. We have introduced the most accurate test in the IVF field for 24-chromosome aneuploidy screening and single gene disorder. At Progenesis, we believe in innovation. Our expert scientists are constantly working to improve our products through research and development. Our goal is to provide our patients with the latest, most advanced technology and information to equip them with the best tools to build healthy families. For more information, please visit www.progenesis.com. #Progenesis #Biotechnology #GeneticTesting #Innovation #IVF #Infertility #Diagnosis

网站
https://progenesis.com/
所属行业
生物技术研究
规模
11-50 人
总部
La Jolla,California
类型
私人持股
创立
2015
领域
Next Generation Sequencing、PGTA、PGTM、Embryo Screening和Genetic Testing

地点

  • 主要

    4150 Regents Park Row, Suite 245

    US,California,La Jolla,92037

    获取路线

Progenesis员工

动态

相似主页

查看职位